MDR-RA is gathering insights from patients, clinicians, policymakers, and advocacy groups across Europe on multi-drug resistance in RA. Their voices highlight treatment fatigue, the need for better tools, and equitable access.
Follow us as we deepen this dialogue.
MDR-RA is gathering insights from patients, clinicians, policymakers, and advocacy groups across Europe on multi-drug resistance in RA. Their voices highlight treatment fatigue, the need for better tools, and equitable access.
Follow us as we deepen this dialogue.
#MDRRA #PatientInvolvement #CoCreation
#MDRRA #PatientInvolvement #CoCreation
By combining clinical data, molecular insights & patient-reported outcomes with AI, MDR-RA aims to guide truly personalised care.
Because every person with RA deserves tailored treatment.
#AI #RA #MDRRA
#WAD2025 #WorldArthritisDay
#WAD2025 #WorldArthritisDay
#WAD2025 #WorldArthritisDay
#WAD2025 #WorldArthritisDay
Beyond clinical value, MDR-RA is testing if the iCare-RA Tool is cost-effective & feasible in real healthcare.
From cost-effectiveness & micro-costing to stakeholder input, we’re building the case for smarter RA care.
🌍💡 #MDRRA #RAresearch #DigitalHealth
Beyond clinical value, MDR-RA is testing if the iCare-RA Tool is cost-effective & feasible in real healthcare.
From cost-effectiveness & micro-costing to stakeholder input, we’re building the case for smarter RA care.
🌍💡 #MDRRA #RAresearch #DigitalHealth
Over 100 patients across Europe will eventually be enrolled to compare standard care vs. AI-supported decisions. A key step toward precision care in difficult-to-treat RA. #MDRRA #AI
MDR-RA is recruiting 80 D2T-RA patients across 16 EU/UK centres. 12-month follow-up with biopsies, imaging, QST & clinical data to power AI-driven iCare-RA and advance precision medicine in RA.
#MDRRA #RAresearch #ClinicalTrial #HorizonEurope #RealWorldEvidence
MDR-RA is recruiting 80 D2T-RA patients across 16 EU/UK centres. 12-month follow-up with biopsies, imaging, QST & clinical data to power AI-driven iCare-RA and advance precision medicine in RA.
#MDRRA #RAresearch #ClinicalTrial #HorizonEurope #RealWorldEvidence
Researchers across Europe are uncovering the molecular clues - from joint tissue to blood biomarkers - to crack drug resistance & enable precision care.
Read how our team is building the first molecular maps of drug-resistant RA www.mdr-ra.eu
Researchers across Europe are uncovering the molecular clues - from joint tissue to blood biomarkers - to crack drug resistance & enable precision care.
Read how our team is building the first molecular maps of drug-resistant RA www.mdr-ra.eu
With the #MDRRA project, that vision is becoming reality.
We’re honoured to collaborate with 14 patient organisations from 12 European countries.
#RAcommunity #PatientEngagement #HealthResearch #HorizonEurope
With the #MDRRA project, that vision is becoming reality.
We’re honoured to collaborate with 14 patient organisations from 12 European countries.
#RAcommunity #PatientEngagement #HealthResearch #HorizonEurope
✅ Progress on data infrastructure & clinical tools
🤝 14 patient orgs joined project
🧬 Observational study & AI tool underway
👏 Great leadership & inspiring opera night!
Stay connected - follow us on LinkedIn & visit our website for updates.
✅ Progress on data infrastructure & clinical tools
🤝 14 patient orgs joined project
🧬 Observational study & AI tool underway
👏 Great leadership & inspiring opera night!
Stay connected - follow us on LinkedIn & visit our website for updates.
Prof. Gremese & Dr. Bruno (HUMANITAS) with Prof. Alivernini (Università Cattolica del Sacro Cuore) at the MDR-RA booth!
Key experts driving MDR-RA project forward — combining clinical excellence with cutting-edge AI to improve care for RA patients.
Follow us @ EULAR and beyond.
Prof. Gremese & Dr. Bruno (HUMANITAS) with Prof. Alivernini (Università Cattolica del Sacro Cuore) at the MDR-RA booth!
Key experts driving MDR-RA project forward — combining clinical excellence with cutting-edge AI to improve care for RA patients.
Follow us @ EULAR and beyond.
Thrilled that our MDR-RA project is present at the EULAR 2025 Congress, taking place 11–14 June in Barcelona!
🔬 Visit our stand O9 – Our research on rheumatoid arthritis and drug repurposing will be featured among the top scientific contributions this year.
Thrilled that our MDR-RA project is present at the EULAR 2025 Congress, taking place 11–14 June in Barcelona!
🔬 Visit our stand O9 – Our research on rheumatoid arthritis and drug repurposing will be featured among the top scientific contributions this year.
#MDRRA #HorizonEU #iCareRA #HealthForAll
#MDRRA #HorizonEU #iCareRA #HealthForAll
✅ Analyzes data
✅ AI-powered recommendations
✅ Supports shared decision-making
✅ Analyzes data
✅ AI-powered recommendations
✅ Supports shared decision-making
✅PrOb-MDR-RA (WP5): Observational trial collecting clinical, imaging & molecular data.
✅iCare-RA Trial (WP7): Testing AI-driven decision support VS standard care.
Stay tuned! #ClinicalTrials #AIinMedicine
✅PrOb-MDR-RA (WP5): Observational trial collecting clinical, imaging & molecular data.
✅iCare-RA Trial (WP7): Testing AI-driven decision support VS standard care.
Stay tuned! #ClinicalTrials #AIinMedicine
🔗 With 15 interconnected Work Packages, we uncover drug resistance in #RA & advance personalized #treatment.
🧩 Key pillars:
✔️ Clinical & molecular phenotyping
✔️ AI-driven decision support
✔️ Trials & patient engagement
Stay tuned ✨
#HorizonEurope #AI #Research
🔗 With 15 interconnected Work Packages, we uncover drug resistance in #RA & advance personalized #treatment.
🧩 Key pillars:
✔️ Clinical & molecular phenotyping
✔️ AI-driven decision support
✔️ Trials & patient engagement
Stay tuned ✨
#HorizonEurope #AI #Research
🌍Funded by #HorizonEU, MDR-RA unites 23 partners to revolutionize treatment for multi-drug-resistant #RheumatoidArthritis
📢Stay tuned for more! #RA #ClinicalResearch #AI
🌍Funded by #HorizonEU, MDR-RA unites 23 partners to revolutionize treatment for multi-drug-resistant #RheumatoidArthritis
📢Stay tuned for more! #RA #ClinicalResearch #AI